(0.09%) 5 521.75 points
(0.14%) 39 898 points
(0.19%) 19 789 points
(-0.01%) $81.62
(0.60%) $2.83
(-0.29%) $2 337.70
(0.15%) $29.57
(0.27%) $1 004.50
(0.00%) $0.931
(-0.03%) $10.53
(-0.01%) $0.788
(-0.85%) $87.25
-4.02% $ 11.94
Live Chart Being Loaded With Signals
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system...
Stats | |
---|---|
Dzisiejszy wolumen | 1.32M |
Średni wolumen | 869 100 |
Kapitalizacja rynkowa | 716.03M |
EPS | $-12.56 ( Q1 | 2024-05-14 ) |
Następna data zysków | ( $-0.690 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.680 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0210 (0.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-17 | Tsai Philip | Buy | 250 000 | Stock option (right to buy) |
2024-06-17 | Tsai Philip | Buy | 0 | |
2024-06-13 | Boylan James P | Buy | 11 333 | Stock option (right to buy) |
2024-06-13 | Schafer Carol | Buy | 11 333 | Stock option (right to buy) |
2024-06-13 | Swain Sandra M | Buy | 11 333 | Stock option (right to buy) |
INSIDER POWER |
---|
-5.64 |
Last 91 transactions |
Buy: 3 860 071 | Sell: 4 251 388 |
Wolumen Korelacja
Immunome, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
VXRT | 0.917 |
FATE | 0.894 |
IDYA | 0.887 |
BHFAP | 0.883 |
CSX | 0.874 |
BASE | 0.874 |
ORMP | 0.868 |
PXLW | 0.866 |
GANX | 0.865 |
CFBK | 0.864 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Immunome, Inc. Korelacja - Waluta/Towar
Immunome, Inc. Finanse
Annual | 2023 |
Przychody: | $14.02M |
Zysk brutto: | $13.29M (94.81 %) |
EPS: | $-5.38 |
FY | 2023 |
Przychody: | $14.02M |
Zysk brutto: | $13.29M (94.81 %) |
EPS: | $-5.38 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-631 000 (0.00 %) |
EPS: | $-3.09 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-5.63 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Immunome, Inc.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej